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Higher regular fat dairy consumption is associated with lower incidence of
metabolic syndrome but not type 2 diabetes
Abstract
Background and aims Limited evidence suggests habitual dairy consumption to be protective against
metabolic syndrome (MetSyn) and type 2 diabetes among older adults. We assessed the association of
baseline consumption of dairy products with the incidence of MetSyn and type 2 diabetes among a
cohort of Australian adults aged 49 years and over. Methods and results A validated 145-item semiquantitative food frequency questionnaire was used to assess food and nutrient intake at baseline. Tenyear incidence of MetSyn and type 2 diabetes were obtained from 1807 and 1824 subjects respectively.
Odds ratios (OR) were calculated by discrete time logistic regression modelling. Compared with subjects
in the lowest intake quartile of regular fat dairy products, those in the highest quartile had a 59% lower
risk of MetSyn (multivariate adjusted OR: 0.41; 95% CI: 0.23-0.71; ptrend = 0.004), after adjustment for risk
factors. Among obese subjects, an association between a high intake of regular fat dairy foods and
reduced risk of type 2 diabetes was also found (age and sex adjusted OR 0.37; 95% CI: 0.16-0.88; ptrend =
0.030), but the association did not persist after adjustment for additional confounders. There was no
association between total dairy consumption and risk of MetSyn or type 2 diabetes. Conclusions We
found an inverse association between regular fat dairy consumption and risk of MetSyn among Australian
older adults. Further studies are warranted to examine the association between weight status, dairy
consumption and risk of type 2 diabetes.
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ABSTRACT
BACKGROUND AND AIMS: Limited evidence suggests habitual dairy consumption to be
protective against metabolic syndrome (MetSyn) and type 2 diabetes among older adults. We
assessed the association of baseline consumption of dairy products with the incidence of MetSyn
and type 2 diabetes among a cohort of Australian adults aged 49 years and over.
METHODS AND RESULTS: A validated 145-item semi-quantitative food frequency
questionnaire was used to assess food and nutrient intake at baseline. Ten-year incidence of
MetSyn and type 2 diabetes were obtained from 1,807 and 1,824 subjects respectively. Odds
ratios (OR) were calculated by discrete time logistic regression modelling. Compared with
subjects in the lowest intake quartile of regular fat dairy products, those in the highest quartile
had a 59% lower risk of MetSyn (multivariate adjusted OR: 0.41; 95% CI: 0.23-0.71; ptrend =
0.004), after adjustment for risk factors. Among obese subjects, an association between a high
intake of regular fat dairy foods and reduced risk of type 2 diabetes was also found (age and sex
adjusted OR 0.37; 95%CI: 0.16-0.88; ptrend = 0.030), but the association did not persist after
adjustment for additional confounders. There was no association between total dairy
consumption and risk of MetSyn or type 2 diabetes.
CONCLUSIONS: We found an inverse association between regular fat dairy consumption and
risk of MetSyn among Australian older adults. Further studies are warranted to examine the
association between weight status, dairy consumption and risk of type 2 diabetes.
(240 words)
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INTRODUCTION
Metabolic syndrome (MetSyn) and type 2 diabetes share common features such as abnormal
glucose homeostasis, elevated blood lipids, and often central obesity. Indeed type 2 diabetes is
considered a component of MetSyn by most international definitions [1-4]. MetSyn was deemed
one of the fasting growing diseases in the world [5, 6]. Instead of a true syndrome, it is best
described as a set of risk factors related to increased risks of cardiovascular diseases [7]. In 1999
– 2000, it was estimated that around 29% of Australian adults aged 25 years or older had MetSyn
[8].

Diet and lifestyle changes are important in the prevention of MetSyn [9, 10] and type 2 diabetes
[11, 12]. Among many foods that may offer protection against MetSyn or type 2 diabetes, dairy
products are one of the most frequently investigated food groups. However, due to the paucity of
prospective studies, evidence on the effects of dairy consumption on risk of MetSyn is
inconclusive [13]. While the Hoorn study [14] in the Netherlands found no association between
dairy consumption (regardless of type) and risk of MetSyn, other studies [7, 15, 16] suggested
dairy intake was protective for MetSyn.

Similarly, some studies [5, 17] show no relationship between dairy consumption and risk of type
2 diabetes but dairy consumption is generally considered to be protective of type 2 diabetes [12,
18], mainly driven by the findings of large scale studies. In a study of 37.183 older women with
an average follow up period of 10 years [19], a significant negative dose-dependent relationship
between total dairy intake and type 2 diabetes incidence was found, although the protective
effect was only seen amongst individuals without a family history of type 2 diabetes. On the
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other hand, Choi et al [20] reported a protective effect of total dairy or low fat dairy amongst 41
254 American males aged 40 – 70 y on type 2 diabetes, regardless of family history of diabetes.

Overall, the limited evidence in older adults [7, 19, 20] suggests dairy consumption may be
protective of MetSyn and/or type 2 diabetes in this age group. To the best of our knowledge no
study had examined the effects of habitual dairy consumption and risk of these two conditions in
older Australians. Here we report on the association between dairy consumption with the tenyear incidence of MetSyn and type 2 diabetes in a relatively large cohort of Australians aged 49
years and above.

METHODS
Study population
The details of the Blue Mountains Eye Study (BMES) have been previously reported [21]. In
brief, the BMES is a population-based cohort study of common eye diseases and other health
conditions in residents aged 49 years and over in the Blue Mountains area, west of Sydney,
Australia. Baseline information was obtained during 1992 – 1994. A total of 3 267 participants
(89.4% of enrolled participants) attempted and returned the food frequency questionnaire (FFQ),
of which 2 900 were usable (79.3% of participants examined). The details of the FFQ data
cleaning process have been reported elsewhere [21]. At ten-years, in 2002-04, 1 824 people who
provided complete FFQ data at baseline attended follow-up examinations including
anthropometric and biochemical assessments, and were included in the present analysis.

Dietary assessment
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Dietary data were collected using a 145-item self-administered semi-quantitative FFQ, modified
for the Australian diet and vernacular from an earlier FFQ by Willett et al [22]. Participants used
a 9-category frequency scale to indicate the usual frequency of consuming individual food items
during the past year. An allowance for seasonal variation of fruit and vegetables was made by
weighting seasonal fruits and vegetables. Dietary intakes were reassessed by the same FFQ every
5 years. The validity of the FFQ has been reported elsewhere [23, 24]. The Spearman correlation
coefficient for total calcium was 0.61, with 71% of calcium results ranked within one quintile
when compared to the weighed food records (WFR) and only 1% of calcium results were grossly
misclassified (i.e. ranked highest by FFQ method and lowest by WFR method, or vice-versa).
Published glycemic index (GI) values [25] were assigned to the food items in the FFQ, and the

dietary GI and glycemic load (GL) were calculated for each subject as
and

respectively, where GIi is the GI (as percentage) of the ith food, and CHOi is

the amount of available carbohydrates in a serving of the ith food.

Nutritional analysis
Nutrient intakes were estimated using the Australian Tables of Food Composition (NUTTAB90)
[26] for the dietary data. Foods listed in the FFQ were categorised into major food categories and
subcategories similar to those used for the 1995 Australian National Nutrition Survey [27]. Dairy
sub-categorisation includes regular milk, reduced fat/skim milk, low fat cheese, regular cheese,
reduced fat dairy dessert (e.g. low fat yoghurt), and medium fat dairy dessert (e.g. custard and
regular yoghurt). For the purpose of this analysis, total dairy included all of the aforementioned
dairy foods; low/reduced fat dairy included ‘reduced fat/skim milk’, ‘reduced fat dairy dessert’
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and ‘low fat cheese’; while regular fat dairy included ‘regular milk’, ‘regular cheese’ and
‘medium fat dairy dessert’. Quartiles of dairy product consumption were based on serves of dairy
consumed per day. The serving sizes used were 250 g for milk, 200 g for yoghurt, 250 mL for
custards, and 40 g for cheeses. A detailed list of food categories and subcategories used in the
analyses can be found in Online Supplemental Table 1.

Definitions of the health outcomes of interest
Incidence of MetSyn was defined as obesity (BMI ≥ 30) and at least two of the following [4]:
a) Elevated blood pressure: systolic BP ≥ 130 mmHg or diastolic BP ≥ 85 mmHg, or on
anti-hypertensive medications, and/or;
b) Triglycerides ≥ 1.7 mmol/L, and/or;
c) HDL cholesterol: females < 1.29 mmol/L or males < 1.03 mmol/L, and/or
d) Fasting blood glucose > 5.6 mmol/L or diagnosed T2DM.
A fasting blood sample was used to assess blood triglycerides, HDL cholesterol and blood
glucose, and blood pressure was measured on the day of the eye examination using standard
auscultatory methods. Incidence of type 2 diabetes was defined as self-reported physician
diagnosis of type 2 diabetes plus taking medication for type 2 diabetes; or fasting blood glucose
≥ 7.0 mmol/L.

Statistical analyses
All statistical analyses were performed using SAS 9.1 (SAS Institute, Lane Cove, NSW,
Australia). Of the 1 824 subjects who attended the examination at ten-years, 17 did not provide
weight and/or height data and were excluded from analyses requiring BMI adjustment or
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stratification. Trend for subject characteristics across quartiles were tested by linear regression
for continuous variables. Pearson χ2 was used to test for difference between quartiles for
categorical variables. Discrete time logistic regression modelling was used to investigate the
associations between quartiles of total, regular fat and low/reduced fat dairy consumption and
risk of MetSyn and type 2 diabetes, where change in dairy intake in the 10-y study period was
taken intake account. There was no interaction between dairy intake and gender and smoking
status and hence the results were not stratified based on these variables. The base model
included adjustment for age and sex only. Model 1 was further adjusted for smoking status,
physical activity (METs), dietary glycemic load, fibre from vegetables (g), total energy intake
and family history of type 2 diabetes. Model 3 included all adjustments from Model 1, as well as
systolic blood pressure (mmHg), BMI status (< 30 versus ≥ 30 kg/m2; in non-stratified analyses
only), HDL cholesterol (mmol/L), total cholesterol (mmol/L) and triglyceride (mmol/L). Models
2 and 4 included all adjustments from Models 1 and 3 respectively, plus additional adjustment
for calcium (mg). Fibre from vegetables was used instead of total fibre as a previous study by our
group had shown that this was the only type of fibre with a significant association to risk of type
2 diabetes mellitus [28].

Ethics approval
This study was conducted according to the guidelines laid down in the Declaration of Helsinki
and all procedures involving human subjects/patients were approved by the Sydney West Area
Health Service and University of Sydney Human Research Ethics Committees. Written,
informed consent was obtained from all subjects/patients.
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RESULTS
The characteristics of the participants at baseline by quartiles of dairy intake are given in Online
Supplemental Table 2. Participants who had higher total dairy intake had higher energy,
calcium, total fat, saturated fat and vegetable fibre intake, dietary GL, as well as lower dietary GI
(all ptrend < 0.001). Similar trends existed for quartiles of regular fat dairy consumption except for
dietary GI, and there were more male (ptrend < 0.001) and smokers (ptrend = 0.020) in the higher
quartiles. For low/reduced fat dairy, there were less male participants and smokers (both ptrend <
0.001) in the higher quartiles. Those who consumed more low/reduced fat dairy had higher
energy (ptrend = 0.003), calcium (ptrend < 0.001) and vegetable fibre intakes (ptrend = 0.005), but
lower intakes of total fat and saturated fat, as well as dietary GI (all ptrend < 0.001). There was no
difference between the history of cardiovascular diseases of the subjects across the quartiles.

Table 1 shows the odds ratios of incident MetSyn according to quartiles of dairy intake. Subjects
in the highest intake quartile of regular fat dairy at baseline had a significantly lower risk of
MetSyn (Model 1: multivariate adjusted odds ratios (OR): 0.41; 95% confidence intervals (CI):
0.23 – 0.71; ptrend = 0.004). The association remains after further adjustment for calcium (Model
2: multivariate adjusted OR: 0.39; 95%CI: 0.22 – 0.70; ptrend = 0.004). No significant
associations between baseline total dairy consumption and ten-year incidence of MetSyn were
observed in any of the models tested. Subjects who had a higher intake of low/reduced fat dairy
had an increased risk of MetSyn in the fully adjusted model (Model 2; ptrend = 0.043). There were
no significant associations or trends between dairy consumption (total, low/reduced fat or regular
fat) and risk of type 2 diabetes (Online Supplemental Table 3).
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We further stratified the analyses by baseline BMI status (Online Supplemental Table 4), in the
base model obese subjects in the highest quartile of regular fat dairy intake were found to be at a
significantly reduced risk of type 2 diabetes (age and sex adjusted OR: 0.37; 95%CI: 0.16 –
0.88), and a significant trend was also observed (ptrend = 0.030). However, these associations did
not persist after adjustment for confounders, or exclusion of the 14% of subjects who switch
BMI category in the 10-year follow-up period (data not shown). No associations between total or
low/reduced fat dairy intake and type 2 diabetes were observed among obese or non-obese
subjects.

DISCUSSION
To our best knowledge this is the first Australian longitudinal study to examine the relationship
between dairy food consumption and risk of incident MetSyn and type 2 diabetes. This study
found that in a population-based cohort of older Australians, people who consumed
approximately two serves of regular fat dairy compared to those who consumed less than one
serve of regular fat dairy (median serve of lowest quartile = 0.1), had a ~59% reduced risk of
developing MetSyn, a relationship not observed with total or low/reduced fat dairy consumption.
There was also a significant association between regular fat dairy consumption and risk of type 2
diabetes amongst obese subjects but not in non-obese subjects.

We found that in the BMES population, an increased low/reduced fat dairy intake was associated
with a lower daily saturated fat intake, which is protective against various components of
MetSyn such as high triglycerides and hyperlipidemia. Our finding of an increase in risk of
MetSyn among those who had higher intakes of low / reduced fat dairy (i.e. 3rd and 4th quartile)
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is therefore surprising. A recent study has found that daily consumption of low fat dairy products
for 8 weeks did not improve metabolic markers related to MetSyn except for a slight decrease in
systolic blood pressure [29], which may partly explain our results.

Due to its higher saturated fat content, regular fat / high fat dairy products were previously
believed to increase the risk of type 2 diabetes as a high saturated fat intake is associated with
insulin resistance [12, 30]. However, cohort studies and a meta-analysis now suggest otherwise,
with higher regular fat / high fat dairy consumption being considered mostly neutral or protective
for type 2 diabetes [18-20]. The results of the present study are consistent with these findings
that higher regular fat dairy consumption may be protective of MetSyn and type 2 diabetes. The
potential harmful effects of higher saturated fat from regular fat dairy products may have been
offset by the protective components of regular fat dairy [31], such as trans-palmitoleate, a fatty
acid nearly unique to ruminant foods [32, 33]. Circulating level of trans-palmitoleate was shown
to be significantly associated with reduced risk of type 2 diabetes (Q5 vs Q1: 62% reduced risk,
95% CI: 38 – 76%, ptrend < 0.001) [32]. Moreover, the protective effect of trans-palmitoleate may
be exerted via the suppression of hepatic fat synthesis, where the latter was strongly associated
with insulin resistance [32, 34].

The association between dairy intake and ten-year incidence of type 2 diabetes could be
mediated by weight status. Pereira et al [15] found that dairy consumption was associated with a
reduced risk of abnormal glucose homeostasis only among subjects who were overweight at
baseline. In agreement, we found a decreasing trend in risk of type 2 diabetes with increasing
baseline intake of regular fat dairy only among obese subjects. However, these results must be
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interpreted with caution due to the small numbers of obese subjects in this subgroup. As
suggested by Pereira et al [15], subjects who were of normal weight at baseline may have a
healthier lifestyle or genetic factors which protect them from getting diabetes, and being
overweight is associated with a greater propensity to develop type 2 diabetes. In addition,
subjects at higher risk of type 2 diabetes may have been advised by healthcare professionals to
switch from regular fat to low/reduced fat dairy and lose weight. It has previously been shown
that higher low/reduced fat dairy intake, in conjunction with an energy restricted diet, may
promote higher weight loss and reduce waist circumference [35], which may reduce the risk of
type 2 diabetes. In the present study 14% of the subjects have switched BMI categories in the 10
year follow-up, however the results did not significantly change when these subjects were
excluded from the analyses.

Further this protective effect observed in obese subjects did not persist after additional
adjustment for confounding variables and calcium. Dairy products are primary sources of
calcium in the Australian diet. While it is possible that dietary calcium may be responsible for
the protective effect of dairy consumption [16, 36], the loss in significance could also be due to a
loss of statistical power due to the large number of adjustments made as well as the relatively
small number of cases in the weight sub-groups.

The strengths of this study include the use of a validated FFQ with a high correlation coefficient
for calcium to assess the dairy consumption of the participants. This is likely to increase the
plausibility of the associations found. The use of a well defined and generally accepted definition
for MetSyn increased the reliability of the incidence data. The long follow up period also
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allowed us to better capture the incidence of MetSyn and type 2 diabetes which take many years
to develop. The present study was, however, limited by the relatively small sample size and the
low incidence of type 2 diabetes, therefore, we cannot rule out the possibility of chance findings.
Furthermore, we are unable to rule out the possibility of residual confounding from other
lifestyle risk factors for MetSyn and/or type 2 diabetes. In addition, the use of self-reported
physician diagnosis may have resulted in some cases of undiagnosed type 2 diabetes, although
this chance was minimized by the additional fasting blood glucose level criterion. While a 75-g
oral glucose tolerance test is considered to be the gold standard of diabetes diagnosis in the
clinical setting, due to the high costs and effort associated, it is not feasible and not commonly
used in large scale epidemiological studies.

In conclusion, we found an inverse association between regular fat dairy consumption and risk of
MetSyn among Australian older adults. Further studies are warranted to examine the association
between weight status, dairy consumption and risk of type 2 diabetes.
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Table 1 - Odds ratios (95% Confidence Intervals) of incident metabolic syndrome according to
quartiles of reduced/low fat, regular fat and total dairy product intake
Q1 (ref)

Q2

Q3

Q4

P for trend

451 / 38
1.00

452 / 47
1.26 (0.81 – 1.95)

1.00

1.21 (0.77 – 1.90)

Model 2

1.00

1.12 (0.68 – 1.83)

452 / 37
0.96 (0.60 –
1.52)
0.86 (0.51 –
1.44)
0.62 (0.24 –
1.62)

0.516

Model 1

452 / 33
0.82 (0.51 –
1.32)
0.72 (0.43 –
1.20)
0.62 (0.33 –
1.16)
459 / 54
2.44 (1.46 –
4.07)
2.33 (1.39 –
3.91)
2.45 (1.45 –
4.13)

445 / 41
1.79 (1.05 –
3.07)
1.66 (0.95 –
2.89)
2.01 (1.05 –
3.83)

0.121

456 / 44
0.91 (0.59 –
1.40)
0.76 (0.48 –
1.20)
0.76 (0.48 –
1.20)

448 / 25
0.52 (0.62 –
0.86)
0.41 (0.23 –
0.71)
0.39 (0.22 –
0.70)

0.018

Total dairy
n / cases
a
Base model
b
c

Reduced/low fat dairy
n / cases
465 / 22
a
Base model
1.00
b

438 / 38
1.63 (0.95 – 2.81)

Model 1

1.00

1.50 (0.86 – 2.60)

Model 2

1.00

1.50 (0.86 – 2.61)

c

Regular fat dairy
n / cases
436 / 45
a
Base model
1.00
b

467 / 41
0.83 (0.54 – 1.29)

Model 1

1.00

0.71 (0.45 – 1.13)

Model 2

1.00

0.71 (0.45 – 1.12)

c

0.332
0.242

0.170
0.043

0.004
0.004

a

Base model adjusted for age and sex
Model 1: Base model with additional adjustments for smoking status, physical activity (metabolic
equivalents), dietary glycemic load, fibre from vegetables (g), total energy intake and family history of
type 2 diabetes
c
Model 2: Model 1 with additional adjustment for calcium (mg)
b
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Online Supplemental Table 2 – Subject characteristics at baseline by quartiles of dairy intake
Q1
Q2
Q3
Q4
Total dairy
Median intake (serves)
0.5
1.2
1.8
3.1
455
461
452
456
n
Age (y)
63.8 ± 8.5
63.5 ± 8.1
63.4 ± 8.3
63.9 ± 8.1
Male (%)
45.1
44.3
37.0
42.1
Smokers (%)
13.2
12.4
11.4
11.1
26.0 ± 4.5
26.3 ± 4.3
26.2 ± 4.1
26.2 ± 4.0
BMI (kg/m2)
Energy (kJ)
7288.8 ± 2358.4 7923.7 ± 2134.2 8873.8 ± 2334.5 10167.4 ± 2567.5
Calcium (mg)
483.0 ± 166.1
717.4 ± 136.3
962.7 ± 160.0
1461.0 ± 331.4
Total fat (g)
63.3 ± 25.9
69.4 ± 23.7
79.3 ± 26.1
91.7 ± 32.7
Saturated fat (g)
23.1 ± 11.1
26.4 ± 10.2
31.2 ± 11.6
38.0 ± 16.1
Vegetable fibre (g)
9.2 ± 4.7
9.6 ± 4.0
10.7 ± 4.4
11.1 ± 5.2
Glycemic index
58.6 ± 4.8
56.8 ± 4.0
55.7 ± 3.8
54.3 ± 3.9
Glycemic load
118.8 ± 44.3
126.3 ± 39.1
137.9 ± 44.6
153.8 ± 45.7
Medical history of
CHD (%)
17.8
15.0
17.5
14.7
Hypertension (%)
55.4
49.3
49.7
50.7
AMI (%)
10.3
7.7
8.7
10.0
Angina (%)
14.3
11.7
14.4
11.2
Stroke (%)
5.4
5.1
5.3
6.7
Low / reduced fat
Median intake (serves)
0.0
0.1
0.9
2.1
452
460
458
454
n
Age (y)
65.1 ± 8.8
62.1 ± 8.4
63.7 ± 8.0
63.8 ± 7.6
Male (%)
55.8
40.2
41.5
31.1
Smokers (%)
16.6
15.2
9.2
7.2
BMI (kg/m2)
25.7 ± 4.1
26.3 ± 4.4
26.4 ± 4.2
26.2 ± 4.2
Energy (kJ)
8812.4 ± 2659.1 8147.5 ± 2685.0 8335.6 ± 2511.8
8959.6 ± 2414.2
Calcium (mg)
773.3 ± 366.4
717.6 ± 343.1
853.1 ± 286.8
1279.8 ± 422.7
Total fat (g)
82.3 ± 30.1
75.6 ± 30.3
73.0 ± 29.5
72.8 ± 26.3
Saturated fat (g)
34.1 ± 14.7
29.8 ± 14.0
27.4 ± 12.7
27.4 ± 12.0
Vegetable fibre (g)
9.9 ± 5.1
9.9 ± 4.8
10.1 ± 4.4
10.6 ± 4.1
Glycemic index
58.3 ± 4.7
57.0 ± 4.5
56.1 ± 3.7
54.0 ± 3.6
Glycemic load
138.1 ± 48.0
126.0 ± 46.1
130.7 ± 42.0
141.9 ± 43.9
Medical history of
CHD (%)
17.0
16.7
16.0
15.3
Hypertension (%)
52.5
51.7
50.1
50.8
AMI (%)
9.7
9.2
8.6
9.3
Angina (%)
14.0
13.5
11.6
12.4
Stroke (%)
4.3
5.8
5.5
7.0

Regular fat
Median intake (serves)
n
Age (y)

0.1
454
63.6 ± 7.8

0.4
457
64.0 ± 8.1

1.0
442
63.4 ± 8.4

1.9
471
63.6 ± 8.8

p valuea
0.780
0.059
0.760
0.745
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.473
0.228
0.510
0.337
0.723
0.805
<0.001
<0.001
0.283
0.003
<0.001
<0.001
<0.001
0.005
<0.001
0.089
0.901
0.898
0.947
0.693
0.369

0.746

Q1
35.7
11.1
26.1 ± 4.3
7312.7 ± 2309.2
705.8 ± 380.7
58.2 ± 23.1
20.1 ± 9.4
9.3 ± 4.2
56.6 ± 4.6
122.5 ± 44.3

Q2
39.8
10.5
26.1 ± 4.3
8141.2 ± 2241.0
848.8 ± 404.4
69.0 ± 24.3
25.6 ± 10.3
10.1 ± 4.2
56.3 ± 4.4
129.2 ± 41.3

Q3
44.3
10.2
26.2 ± 4.3
8718.5 ± 2391.8
856.8 ± 308.4
78.3 ± 25.1
30.6 ± 10.5
10.2 ± 4.6
56.5 ± 4.5
135.0 ± 43.9

Q4
48.4
16.1
26.2 ± 3.9
10026.6 ± 2603.5
1198.9 ± 409.9
97.4 ± 29.0
41.9 ± 13.3
10.9 ± 5.3
56.0 ± 4.2
149.4 ± 47.6

p valuea
<0.001
0.020
0.782
<0.001
<0.001
<0.001
<0.001
<0.001
0.084
<0.001

Male (%)
Smokers (%)
BMI (kg/m2)
Energy (kJ)
Calcium (mg)
Total fat (g)
Saturated fat (g)
Vegetable fibre (g)
Glycemic index
Glycemic load
Medical history of
CHD (%)
16.3
15.2
18.4
15.1
0.494
Hypertension (%)
51.8
54.6
48.9
49.7
0.304
AMI (%)
8.6
9.7
9.2
9.2
0.951
Angina (%)
12.4
11.4
15.8
12.0
0.182
Stroke (%)
5.1
6.9
5.1
5.4
0.590
Values are expressed as mean ± SD except specified otherwise.
a
p for trend tested by linear regression for continuous variables, and p value were tested by Pearson’s χ2 for
categorical variables.
CHD – coronary heart diseases; AMI – acute myocardial infarction

Online Supplemental Table 3 - Odds ratios (95% Confidence Intervals) of incident type 2 diabetes
according to quartiles of reduced/low fat, regular fat and total dairy product intake
Q1 (ref)

Q2

Q3

Q4

P for trend

Total dairy
n / cases
455 / 35
461 / 47
452 / 30
456 / 33
a
Base model
1.00
1.33 (0.85 – 2.09) 0.80 (0.49 – 1.32) 0.90 (0.55 – 1.46)
0.310
b
Model 3
1.00
1.15 (0.71 – 1.87) 0.80 (0.46 – 1.40) 0.96 (0.54 – 1.71)
0.710
c
Model 4
1.00
1.29 (0.74 – 2.26) 1.00 (0.47 – 2.11) 1.50 (0.47 – 4.77)
0.568
Reduced/low fat dairy
n / cases
452 / 32
460 / 44
458 / 33
454 / 36
a
Base model
1.00
1.28 (0.79 – 2.05) 0.93 (0.56 – 1.53) 1.00 (0.61 – 1.64)
0.482
b
Model 3
1.00
1.29 (0.77 – 2.14) 0.85 (0.49 – 1.46) 1.00 (0.58 – 1.71)
0.482
c
Model 4
1.00
1.28 (0.77 – 2.14) 0.87 (0.50 – 1.52) 1.09 (0.57 – 2.09)
0.764
Regular fat dairy
n / cases
454 / 41
457 / 37
442 / 39
471 / 28
a
Base model
1.00
0.89 (0.56 – 1.41) 0.97 (0.62 – 1.53) 0.65 (0.40 – 1.07)
0.106
b
Model 3
1.00
1.02 (0.62 – 1.69) 1.01 (0.61 – 1.67) 0.83 (0.47 – 1.48)
0.496
c
Model 4
1.00
1.04 (0.63 – 1.72) 1.01 (0.61 – 1.68) 0.87 (0.48 – 1.57)
0.596
a
Base model adjusted for age and sex
b
Model 3: Model 1 with additional adjustments for systolic blood pressure (mmHg), baseline BMI status (< 30
vs ≥ 30 kg/m2), HDL cholesterol (mmol/L), total cholesterol (mmol/L) and triglyceride (mmol/L).
c
Model 4: Model 3 with additional adjustment for calcium (mg)

Online Supplemental Table 4 – Odds ratios (95% Confidence Intervals) of type 2 diabetes mellitus according to quartiles of reduced/low fat, regular fat and total
dairy product intake, stratified by baseline BMI status
BMI < 30
BMI ≥ 30
Q1
P for
Q1
Type of
Q2
Q3
Q4
Q2
Q3
Q4
(ref)
trend
(ref)
dairy
Total dairy
n / case
378 / 21
376 / 26
374 / 22
384 / 24
74 / 13
79 / 20
73 / 8
69 / 9
a
Base model
1.00
1.23 (0.68 – 2.21) 0.98 (0.54 – 1.81) 1.06 (0.59 – 1.93)
0.970
1.00
1.62 (0.77 – 3.41) 0.60 (0.24 – 1.50) 0.74 (0.30 – 1.81)
b
Model 3
1.00
1.10 (0.58– 2.05) 1.18 (0.61 – 2.28) 1.17 (0.59 – 2.36)
0.664
1.00
1.02 (0.44 – 2.36) 0.29 (0.10 – 0.88) 0.45 (0.15 – 1.34)
c
Model 4
1.00
1.04 (0.52 – 2.08) 1.07 (0.45 – 2.54) 0.96 (0.25 – 3.76)
0.952
1.00
2.16 (0.71 – 6.53) 1.03 (0.21– 4.97) 4.78 (0.44 – 52.47)
Reduced fat and/or low fat
n / case
389 / 22
374 / 26
374 / 19
375 / 26
61 / 10
81 / 17
80 / 13
73 / 10
a
Base model
1.00
1.15 (0.64 – 2.06) 0.80 (0.43 – 1.50) 1.06 (0.59 – 1.92)
0.903
1.00
1.24 (0.53 – 2.88) 0.99 (0.41 – 2.38) 0.84 (0.33 – 2.14)
b
Model 3
1.00
1.14 (0.61 – 2.15) 0.73 (0.37 – 1.43) 1.02 (0.54 – 1.92)
0.763
1.00
1.50 (0.58 – 3.86) 1.09 (0.42 – 2.85) 0.73 (0.25 – 2.09)
c
Model 4
1.00
1.15 (0.61 – 2.16) 0.70 (0.35 – 1.38) 0.86 (0.40 – 1.85)
0.413
1.00
1.67 (0.64 – 4.38) 1.72 (0.62 – 4.78) 1.73 (0.49 – 6.13)
Regular fat
n / case
366 / 22
387 / 24
372 / 27
387 / 20
82 / 19
65 / 11
69 / 12
79 / 8
a
Base model
1.00
1.05 (0.58 – 1.89) 1.25 (0.70 – 2.22) 0.89 (0.48 – 1.65)
0.708
1.00
0.68 (0.31 – 1.50) 0.66 (0.31 – 1.43) 0.37 (0.16 – 0.88)
b
Model 3
1.00
1.23 (0.65 – 2.30) 1.40 (0.73 – 2.66) 1.30 (0.64 – 2.68)
0.509
1.00
0.88 (0.36 – 2.16) 0.65 (0.27 – 1.59) 0.42 (0.15 – 1.19)
c
Model 4
1.00
1.21 (0.65 – 2.28) 1.40 (0.73 – 2.65) 1.25 (0.60 – 2.62)
0.580
1.00
1.02 (0.41 – 2.54) 0.64 (0.26 – 1.58) 0.57 (0.20 – 1.65)

BMI – Body mass index
a
Base model adjusted for age and sex
b
c

Model 3: Model 1 with additional adjustments for systolic blood pressure (mmHg), HDL cholesterol (mmol/L), total cholesterol (mmol/L) and triglyceride (mmol/L).
Model 4: Model 3 with additional adjustment for calcium (mg)

P for
trend
0.220
0.078
0.288
0.438
0.230
0.622
0.030
0.079
0.201

